Microsatellite instability and mismatch repair protein deficiency: equal predictive markers?
Current clinical guidelines recommend mismatch repair (MMR) protein immunohistochemistry (IHC) or molecular microsatellite instability (MSI) tests as predictive markers of immunotherapies. Most of the pathological guidelines consider MMR protein IHC as the gold standard test to identify cancers with...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Frontiers Media S.A.
2024-04-01
|
| Saila: | Pathology and Oncology Research |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.por-journal.com/articles/10.3389/pore.2024.1611719/full |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|